Evidence of recombination in intrapatient populations of hepatitis C virus.
Hepatitis C virus (HCV) is a major cause of liver disease worldwide and a potential cause of substantial morbidity and mortality in the future. HCV is characterized by a high level of genetic heterogeneity. Although homologous recombination has been demonstrated in many members of the family Flaviviridae, to which HCV belongs, there are only a few studies reporting recombination on natural populations of HCV, suggesting that these events are rare in vivo. Furthermore, these few studies have focused on recombination between different HCV genotypes/subtypes but there are no reports on the extent of intra-genotype or intra-subtype recombination between viral strains infecting the same patient. Given the important implications of recombination for RNA virus evolution, our aim in this study has been to assess the existence and eventually the frequency of intragenic recombination on HCV. For this, we retrospectively have analyzed two regions of the HCV genome (NS5A and E1-E2) in samples from two different groups: (i) patients infected only with HCV (either treated with interferon plus ribavirin or treatment naïve), and (ii) HCV-HIV co-infected patients (with and without treatment against HIV). The complete data set comprised 17712 sequences from 136 serum samples derived from 111 patients. Recombination analyses were performed using 6 different methods implemented in the program RDP3. Recombination events were considered when detected by at least 3 of the 6 methods used and were identified in 10.7% of the amplified samples, distributed throughout all the groups described and the two genomic regions studied. The resulting recombination events were further verified by detailed phylogenetic analyses. The complete experimental procedure was applied to an artificial mixture of relatively closely viral populations and the ensuing analyses failed to reveal artifactual recombination. From these results we conclude that recombination should be considered as a potentially relevant mechanism generating genetic variation in HCV and with important implications for the treatment of this infection.
Sentandreu
Vicente
V
Institut Cavanilles de Biodiversitat i Biologia Evolutiva, Universitat de València Valencia, Spain.
Jiménez-Hernández
Nuria
N
Torres-Puente
Manuela
M
Bracho
María Alma
MA
Valero
Ana
A
Gosalbes
María José
MJ
Ortega
Enrique
E
Moya
Andrés
A
González-Candelas
Fernando
F
D000465:Algorithms; D000998:Antiviral Agents / Q000494:pharmacology; D014644:Genetic Variation; D016678:Genome; D005838:Genotype; D016174:Hepacivirus / Q000378:metabolism*; D016013:Likelihood Functions; D008957:Models, Genetic; D010802:Phylogeny; D011995:Recombination, Genetic; D012984:Software
D000998:Antiviral Agents
J Med Virol. 1997 Oct;53(2):118-26
9334922
Proteins. 2000 Aug 15;40(3):355-66
10861927
Hepatology. 2005 Oct;42(4):962-73
16149085
J Gen Virol. 2003 Feb;84(Pt 2):429-440
12560576
Arch Virol. 2003 Jul;148(7):1247-67
12827459
J Virol. 2007 May;81(9):4591-603
17301154
Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7352-7
10377418
Clin Microbiol Rev. 2000 Apr;13(2):223-35
10755999
J Virol. 2007 Apr;81(8):4357-62
17267503
J Gen Virol. 2007 Jan;88(Pt 1):123-133
17170444
J Gen Virol. 2004 Nov;85(Pt 11):3173-3188
15483230
Virology. 1997 Apr 14;230(2):217-27
9143277
Virol J. 2004 Dec 09;1:13
15588294
J Infect Dis. 2006 Dec 1;194(11):1529-36
17083037
J Gen Virol. 2004 Jan;85(Pt 1):31-37
14718617
Nucleic Acids Res. 1998 Apr 1;26(7):1819-25
9512558
N Engl J Med. 2001 Jul 5;345(1):41-52
11439948
J Virol. 1993 Jul;67(7):3923-30
7685404
Bioinformatics. 2000 Jun;16(6):562-3
10980155
J Med Virol. 2007 Jan;79(1):35-40
17133546
Mol Biol Evol. 2001 Feb;18(2):254-61
11158384
Gastroenterology. 2006 Jul;131(1):76-84
16831592
J Gen Virol. 1998 Jun;79 ( Pt 6):1373-81
9634077
Gastroenterology. 1997 Aug;113(2):567-72
9247477
J Virol. 2001 Jul;75(14):6256-64
11413291
Virology. 1999 Dec 20;265(2):218-25
10600594
Hepatology. 1995 Jul;22(1):30-5
7541387
Nat Rev Microbiol. 2004 Apr;2(4):279-88
15031727
J Virol. 2004 May;78(10):5170-83
15113899
J Med Virol. 1996 Jul;49(3):155-60
8818959
J Med Virol. 2001 Jan;63(1):8-16
11130893
Virology. 2006 Sep 1;352(2):357-67
16781757
J Gen Virol. 1993 Nov;74 ( Pt 11):2391-9
8245854
Hepatology. 1997 May;25(5):1250-4
9141446
J Infect Dis. 1998 Apr;177(4):839-47
9534954
Bioinformatics. 2002 Mar;18(3):502-4
11934758
Hepatology. 1992 Sep;16(3):619-24
1380477
Antivir Ther. 2004 Apr;9(2):275-86
15134190
Virology. 1993 Jul;195(1):297-301
7686313
J Clin Invest. 1995 Jul;96(1):224-30
7542279
Virol J. 2006 Oct 24;3:87
17062150
J Med Virol. 2006 Nov;78(11):1423-8
16998890
Virol J. 2006 Nov 15;3:95
17107614
Eur J Gastroenterol Hepatol. 2002 Aug;14(8):879-81
12172410
J Med Virol. 2003 May;70(1):62-73
12629645
AIDS Res Hum Retroviruses. 2006 Apr;22(4):357-66
16623640
AIDS Res Hum Retroviruses. 1995 Nov;11(11):1423-5
8573403
Ann Intern Med. 2004 Mar 2;140(5):346-55
14996676
Hepatology. 1994 May;19(5):1321-4
8175159
J Hepatol. 1997 Jul;27(1):72-7
9252076
J Viral Hepat. 2008 Mar;15(3):188-99
18233992
J Virol. 2007 Aug;81(15):8211-24
17522222
Infection. 2000 Jan-Feb;28(1):21-5
10697786
J Infect Dis. 2001 Apr 15;183(8):1195-203
11262201
Syst Biol. 2003 Oct;52(5):696-704
14530136
Virology. 1992 May;188(1):331-41
1314459
Bioinformatics. 1998;14(9):817-8
9918953
J Viral Hepat. 2006 Aug;13(8):532-7
16901283
Hepatology. 1997 Mar;25(3):745-9
9049229
Antivir Ther. 2005;10(1):1-11
15751759
Gut. 2004 Sep;53(9):1345-51
15306598
J Gen Virol. 1999 Oct;80 ( Pt 10):2535-2543
10573145
Bioinformatics. 2005 Jan 15;21(2):260-2
15377507
J Gen Virol. 2007 Aug;88(Pt 8):2198-2203
17622623
J Hepatol. 1998 Sep;29(3):352-61
9764980
J Virol. 2006 Aug;80(15):7569-77
16840336
Infect Genet Evol. 2007 Jul;7(4):476-83
17369105
Proc Biol Sci. 2002 Jan 22;269(1487):137-42
11798428
J Virol. 2002 Apr;76(8):4034-43
11907242
J Gen Virol. 1997 Feb;78 ( Pt 2):321-8
9018053
Hepatology. 2006 Nov;44(5):1355-61
17058236
J Gen Virol. 2004 Jul;85(Pt 7):1853-1857
15218169
J Hepatol. 1999 Jun;30(6):1023-7
10406179
Lancet Infect Dis. 2005 Sep;5(9):558-67
16122679
N Engl J Med. 1996 Jan 11;334(2):77-81
8531962
Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3468-72
1314389
Infect Genet Evol. 2005 Mar;5(2):131-9
15639745
Hepatology. 1997 Mar;25(3):740-4
9049228
J Virol. 2001 Jun;75(12):5703-10
11356980
J Virol. 2007 Apr;81(8):3693-703
17287280
J Infect Dis. 2007 Feb 15;195(4):519-24
17230411
J Infect Dis. 2007 Jun 15;195(12):1765-73
17492592
Methods Mol Biol. 2000;132:115-30
10547834
J Virol. 2005 Mar;79(5):3071-83
15709027
Clin Microbiol Infect. 2005 Feb;11(2):86-94
15679481
Am J Gastroenterol. 1999 Sep;94(9):2487-95
10484013
Pharmacol Ther. 1998 Apr;78(1):29-46
9593328
Bioinformatics. 2000 Jul;16(7):573-82
11038328
Nucleic Acids Res. 1997 Dec 15;25(24):4876-82
9396791
Semin Liver Dis. 2000;20(1):103-26
10895435
Science. 2000 Apr 14;288(5464):339-44
10764648
Environ Microbiol. 2002 Aug;4(8):482-6
12153589
J Infect Dis. 2004 Oct 15;190(8):1396-403
15378431
J Mol Evol. 1992 Feb;34(2):126-9
1556748
J Infect Dis. 1997 May;175(5):1101-7
9129072
J Med Virol. 1999 Aug;58(4):353-8
10421401
J Hepatol. 2005 Apr;42(4):491-8
15763335
J Virol. 2005 May;79(10):6349-57
15858018